Global Health Emergency or Corporate Payday?

The World Health Organisation (WHO) has declared Monkeypox a global public health emergency, triggering emergency powers to drive vaccine sales that benefit big pharmaceutical companies with ties to the organisation. This decision serves corporate interests rather than public health. Regulatory agencies that are meant to protect the public fall under undue influence from the industries they regulate. The WHO is a corrupt organisation that is designed to funnel taxpayer money to its billionaire donors. Australian taxpayers gave $30 million to the WHO last year, likely as a show of loyalty.

Transparency is lacking. Major donors include Gavi, a vaccine alliance funded by corporations tied to predatory giants like BlackRock and Vanguard, who also own large shares in pharmaceutical companies. The WHO’s Monkeypox emergency, declared solely by its director-general, Tedros Ghebreyesus, highlights the unchecked power of the position. This decision created a market for four already-approved vaccines linked to companies backed by BlackRock and Vanguard, ensuring massive profits for their shareholders. A new Monkeypox vaccine is expected soon, likely fast-tracked by compromised regulators like Australia’s Therapeutic Goods Administration (TGA).

The WHO previously tried to raise alarm over Monkeypox but found little public concern, so they rebranded it as “Mpox” to push vaccine sales. This benefits the predatory billionaires who control vaccine companies, funnel money to Gavi and the WHO, and fund political parties, including Australia’s Liberal and Labor parties. Recent revelations show Anthony Fauci concealed plans to engineer a more deadly and highly transmissible Mpox virus. This “gain-of-function” research has pandemic potential and should be stopped immediately. It’s troubling that Australia’s CSIRO was involved in gain-of-function research for COVID-19, yet faces no consequences.

The WHO and the TGA have failed in their regulatory duties, serving political agendas rather than public interest. During COVID, the TGA prioritised government control over public health, and there are concerns the same will happen again with Mpox. Every Monkeypox case should be verified through public lab tests, especially as redacted data was used to justify COVID measures that harmed public health.

The time of blind trust in the WHO’s narrative is over; it’s now the age of ‘prove it’.

Transcript

The UN’s World Health Organization, the WHO, has declared monkeypox a public health emergency of international concern. This triggers WHO emergency powers to drive vaccine sales to financially benefit big pharmaceutical companies that donate to the WHO through their other commercial and ownership interests. The first thing a house of review like our Senate should do is ask, ‘Is this a legitimate decision?’ The answer is: it is not, no. The UN WHO has succumbed to regulatory capture—a troubling development in governance. That may plunge Western society into serfdom under large corporations. 

Regulatory capture occurs where a regulatory agency mandated to oversee and enforce rules to protect the public interest ends up under undue influence from companies with vested interests such as the entities it’s meant to regulate or special interest groups. This can result in the agency making decisions that prioritise the interests of these parties over the broader public interest. The New South Wales government lists six areas for regulatory capture: adherence to public interest principles; organisational culture; structure; processes; transparency; and staff experience. The WHO fails all six. 

I’ve often spoken about the corruption, cronyism and illegal behaviour of the World Health Organization; some of my WHO speeches are on my website. The WHO fails to hold staff accountable for misbehaviour, including rape and sexual assault. Its own investigators conclude the WHO is ‘rotten with rapists’—their words. It is a failure of organisational culture and of staffing quality. The WHO is a corrupt organisation whose decisions benefit its billionaire sponsors with substantial health interests. The scam is simple: take a disease that’s around for generations—firstly the flu, and more recently bird flu and now monkeypox; plant scary stories in a media desperate for clickbait articles; use the media driven fear to declare a pandemic; and then—payday!—mandate vaccines financially benefiting the billionaires that funded the media scare. This betrays the public interest. 

The WHO is a con, a fraud and a criminal enterprise designed to transfer wealth from taxpayers into the pockets of their billionaire donors and owners. It is an organisation to which Australian taxpayers gave $30 million last year despite them having $8 billion in financial assets; that donation was likely more about fealty than financing. Identifying the WHO’s donors is difficult since its annual accounts show 32 per cent of donations as ‘other’—another failure of transparency. One of the WHO’s major donors is Gavi, the globalist vaccine alliance of international academics, bureaucrats and pharmaceutical companies funded through corporate donations from companies whose share registers feature investment funds like BlackRock and Vanguard. They feature on big pharma share registries; they own big pharma. If Australia had racketeering laws this arrangement would be illegal. This is a failure in structure. 

The monkeypox declaration came from the WHO director-general, Tedros Ghebreyesus, acting alone. The process for making such an important decision is not meaningfully regulated and gives Ghebreyesus too much power to direct a worldwide health response. This is a failure of process, and it’s deliberate. The proclamation is designed to create an international market for new monkeypox vaccines. The WHO already have four approved vaccines for monkeypox: cidofovir, distributed through Pfizer; brincidofovir, manufactured and distributed through Chimerix, whose controlling shareholders include Vanguard and predatory wealth fund cronies; TPOXX, from Siga Pharmaceuticals, with shareholders BlackRock and Vanguard; and ACAM2000 from Emergent Biosolutions, whose largest shareholders are—wait for it—BlackRock and Vanguard. With these drugs the world’s predatory billionaires have decided it’s time for another fundraiser. All four drugs are off-label use—so, any day now, expect a killer new vaccine for monkeypox to be given the hosanna palm frond parade through our disgraced regulators like Canberra’s Therapeutic Goods Administration, the TGA. 

The WHO tested this scam a few years ago with a minor media fear campaign that discovered the public didn’t take something called monkeypox seriously. So they rebranded it as mpox. Amusingly, they claimed the name monkeypox was insulting to monkeys; monkeys have feelings too, you know! So mpox is monkeypox rebranded to sell more vaccines from vaccine companies who funnel the profits to the world’s predatory billionaires—those same billionaires who own the corporations that donate to Gavi and the WHO as well as fill the coffers of political parties around the world, including massive donations to both cheeks of the Liberal-Labor uniparty in this country. 

Last Tuesday, American congressional investigators revealed that, for nearly nine years, Anthony Fauci concealed plans to engineer a pandemic-capable mpox virus with high transmissibility and a case fatality rate of up to 15 per cent. That’s homicide. The gain-of-function project proposed through NIAID in America from virologist Bernard Moss was to splice genes conferring high pathogenicity from the clade I virus into the more transmissible clade II virus. The new chimeric virus or combined virus could have retained up to a 15 per cent fatality rate and a 2.4 reproductive rate—a measure of transmissibility—meaning, on average, every sick person could infect up to 2.4 other people, giving it pandemic potential. It’s marvellous, what it’s designed to do! 

We know gain-of-function research produced the COVID-19 virus. Is this monkeypox outbreak also man-made? 

Gain-of-function research serves no useful purpose and should be terminated immediately. It’s deeply troubling that Australia’s CSIRO admitted and bragged about its involvement in gain-of-function research that produced COVID-19. And now an online meme simply says: ‘They’re doing it again because you didn’t punish them last time.’ That’s truth indeed. 

The WHO fails all six elements of regulatory capture and so does Australia’s Therapeutic Goods Administration, the TGA. The TGA is not acting in public interest, which former New South Wales deputy ombudsman Chris Wheeler considers fundamental to representative democratic government. The TGA may claim that, during COVID, it was caught between the parliament, its direct employer, and the wider public. It chose to serve the government’s need for air cover for controls decided on political, not medical, grounds. The TGA should have read the findings of the 1990 WA Inc royal commission, which found: 

The institutions of government and the officials and agencies of government exist for the public, to serve the interests of the public. 

That’s clear. Yet, during COVID, the TGA chose a different path: to support their own agency, to the detriment of the public. What will the TGA do this time, with monkeypox? 

Monkeypox is transmitted through direct contact from sexual activity or intravenous drug use. A Philpot scientific study found 98.7 per cent of infections resulted from gay male sexual transmission. Transmission can occur through direct personal contact of the infected site. Infected animals can spread the disease. Asymptomatic spread, though, is, like COVID, an assertion with no evidence. The clade Ia variant of monkeypox can affect children. The clades currently circulating, though, clade Ib and II, have not been proven to infect children. 

Australia has two monkeypox vaccines approved for over-18s. Both are off-label repurposed drugs approved for smallpox. JYNNEOS from Bavarian Nordic uses cidofovir, which I mentioned earlier, as the active ingredient. Bavarian Nordic have an application in to America’s Food and Drug Administration to give this vaccine to children aged 12 to 18 and are in early testing to support their application to extend use to children aged two and above—two and above! Why does a child need a vaccine against a disease that’s predominately only transmitted through sexual contact or intravenous drug use? The case for a monkeypox vaccination program must be a very high bar for any person who does not engage in risky sexual activity. 

TGA’s website data from the 2022 monkeypox round of vaccinations in Australia shows 3,163 adverse events per 100,000 vaccinations—a staggeringly high three per cent. I note a study published in the journal Frontiers in Medicine, with authors from the University of New South Wales, entitled ‘Autoimmune blistering skin diseases triggered by COVID-19 vaccinations: an Australian case series’. This report found that COVID-19 vaccination either caused the recipient to develop autoimmune blistering disease or made the recipient’s existing condition worse. The cases are extremely rare, and, for once, I can agree with the TGA. I alert Australia to the chance that these outbreaks of a related disease could be mistaken for monkeypox. I note that autoimmune diseases and shingles—that is, herpes zoster—can intersect, and both are side effects of the COVID vaccines. If the Senate is going to be called on to support a monkeypox response, then it’s essential every case is verified through publicly disclosed laboratory testing. 

Page after page of redacted data was used to support COVID measures and the damage to public health is undeniable. It’s homicide. ‘Safe and effective’ was not one lie; it was two. People are not believing the UN World Health Organization mpox narrative. The time for blind trust is over. We’re now in the age of ‘prove it’.